NCT07073248

Brief Summary

This study aims to evaluate the effects and clinical feasibility of non-invasive brain stimulation protocols, specifically intermittent Theta Burst Stimulation, as part of rehabilitation interventions for motor recovery of upper extremity in the chronic phase after stroke. It also seeks to explore the underlying mechanisms by investigating changes of functional and structural brain networks.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
56mo left

Started Nov 2025

Longer than P75 for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress10%
Nov 2025Dec 2030

First Submitted

Initial submission to the registry

July 9, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 18, 2025

Completed
4 months until next milestone

Study Start

First participant enrolled

November 1, 2025

Completed
5.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2030

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2030

Last Updated

November 21, 2025

Status Verified

August 1, 2025

Enrollment Period

5.1 years

First QC Date

July 9, 2025

Last Update Submit

November 20, 2025

Conditions

Keywords

strokeiTBSTMSMotor cortexchronic stroke patientshand dexterityHemiparesisTranscrania Magnetic Stimulationintermittent Theta Burst Stimulation

Outcome Measures

Primary Outcomes (1)

  • Fugl-Meyer Assessment - Upper Extremity

    used to quantify recovery of sensorimotor function in the upper extremity after a stroke. It is a 63 item test scored on a 3-level ordinal scale. The score ranges from 0 to 126 points. A higher score indicates recovery of sensorimotor function.

    At baseline, after completion of the 5 week intervention to assess change as well at 12 weeks follow up.

Secondary Outcomes (14)

  • Modified Ashworth Scale (MAS)

    At baseline, after completion of the 5 week intervention to assess change as well at 12 weeks follow up.

  • Neuroflexor

    At baseline, after completion of the 5 week intervention to assess change as well at 12 weeks follow up.

  • Box and Block Test (BBT)

    At baseline, after completion of the 5 week intervention to assess change as well at 12 weeks follow up.

  • Action Research Arm Test (ARAT)

    At baseline, after completion of the 5 week intervention to assess change as well at 12 weeks follow up.

  • Dextrain Manipulandumâ„¢

    At baseline, after completion of the 5 week intervention to assess change as well at 12 weeks follow up.

  • +9 more secondary outcomes

Other Outcomes (3)

  • National Institutes of Health Stroke Scale (NIHSS)

    At baseline

  • Barthel Index (BI)

    At baseline.

  • Theoretical Framework of Acceptability questionnaire

    After completion of the 5 week intervention to assess acceptability.

Study Arms (2)

Ipsilesional motor cortex iTBS and conventional rehabilitation

EXPERIMENTAL

The experimental group will receive intermittent theta burst stimulation on the ipsilesional motor cortex followed by 45 minutes of conventional rehabilitation interventions involving the upper extremity led or instructed by a physiotherapist.

Device: Intermittent Theta Burst Stimulation

Ipsilesional motor cortex sham-iTBS and conventional rehabilitation

SHAM COMPARATOR

The placebo group will receive sham intermittent theta burst stimulation on the ipsilesional motor cortex followed by 45 minutes of conventional rehabilitation interventions involving the lower extremity led or instructed by a physiotherapist.

Device: Sham Intermittent Theta Burst Stimulation

Interventions

iTBS protocol: 600 pulses at 80% of AMT for 190 sec on the ipsilesional motor cortex, targeted with the support of a neuronavigational system, 15 sessions over a period of 5 weeks

Also known as: iTBS, TMS
Ipsilesional motor cortex iTBS and conventional rehabilitation

It is identical to its active version, replicates operational sounds, and delivers a very shallow magnetic field to mimic the sensation of magnetic stimulation

Ipsilesional motor cortex sham-iTBS and conventional rehabilitation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age over 18
  • Chronic stroke (\>6 months)
  • Residual hemiparesis FM-UE\>17

You may not qualify if:

  • Metal implants
  • Epilepsy/seizures
  • Pregnancy
  • Claustrophobia (related to MRIs exams)
  • Severe cognitive impairment
  • Untreated or unstable depression/anxiety
  • Other disabilities prohibiting intensive physical training

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Rehabilitation Medicine, Danderyd Hospital, Danderyd, Stockholm 18288, Stockholm

Stockholm, Sweden

RECRUITING

Related Publications (8)

  • Lemon RN. Descending pathways in motor control. Annu Rev Neurosci. 2008;31:195-218. doi: 10.1146/annurev.neuro.31.060407.125547.

    PMID: 18558853BACKGROUND
  • Zhang JJ, Bai Z, Fong KNK. Priming Intermittent Theta Burst Stimulation for Hemiparetic Upper Limb After Stroke: A Randomized Controlled Trial. Stroke. 2022 Jul;53(7):2171-2181. doi: 10.1161/STROKEAHA.121.037870. Epub 2022 Mar 23.

    PMID: 35317611BACKGROUND
  • Zhang JJ, Sui Y, Sack AT, Bai Z, Kwong PWH, Sanchez Vidana DI, Xiong L, Fong KNK. Theta burst stimulation for enhancing upper extremity motor functions after stroke: a systematic review of clinical and mechanistic evidence. Rev Neurosci. 2024 Apr 29;35(6):679-695. doi: 10.1515/revneuro-2024-0030. Print 2024 Aug 27.

    PMID: 38671584BACKGROUND
  • Jiang T, Wei X, Wang M, Xu J, Xia N, Lu M. Theta burst stimulation: what role does it play in stroke rehabilitation? A systematic review of the existing evidence. BMC Neurol. 2024 Feb 1;24(1):52. doi: 10.1186/s12883-023-03492-0.

    PMID: 38297193BACKGROUND
  • van Lieshout ECC, van der Worp HB, Visser-Meily JMA, Dijkhuizen RM. Timing of Repetitive Transcranial Magnetic Stimulation Onset for Upper Limb Function After Stroke: A Systematic Review and Meta-Analysis. Front Neurol. 2019 Dec 3;10:1269. doi: 10.3389/fneur.2019.01269. eCollection 2019.

    PMID: 31849827BACKGROUND
  • Lefaucheur JP, Andre-Obadia N, Antal A, Ayache SS, Baeken C, Benninger DH, Cantello RM, Cincotta M, de Carvalho M, De Ridder D, Devanne H, Di Lazzaro V, Filipovic SR, Hummel FC, Jaaskelainen SK, Kimiskidis VK, Koch G, Langguth B, Nyffeler T, Oliviero A, Padberg F, Poulet E, Rossi S, Rossini PM, Rothwell JC, Schonfeldt-Lecuona C, Siebner HR, Slotema CW, Stagg CJ, Valls-Sole J, Ziemann U, Paulus W, Garcia-Larrea L. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clin Neurophysiol. 2014 Nov;125(11):2150-2206. doi: 10.1016/j.clinph.2014.05.021. Epub 2014 Jun 5.

    PMID: 25034472BACKGROUND
  • Christiansen MG, Senko AW, Anikeeva P. Magnetic Strategies for Nervous System Control. Annu Rev Neurosci. 2019 Jul 8;42:271-293. doi: 10.1146/annurev-neuro-070918-050241. Epub 2019 Apr 2.

    PMID: 30939100BACKGROUND
  • Fan H, Song Y, Cen X, Yu P, Biro I, Gu Y. The Effect of Repetitive Transcranial Magnetic Stimulation on Lower-Limb Motor Ability in Stroke Patients: A Systematic Review. Front Hum Neurosci. 2021 Sep 1;15:620573. doi: 10.3389/fnhum.2021.620573. eCollection 2021.

    PMID: 34539362BACKGROUND

MeSH Terms

Conditions

StrokeHemiplegiaParesis

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesParalysisNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Susanne Palmcrantz, PhD, Associate Professor

    Dep of Clinical Sciences, Karolinska Institutet

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Susanne Palmcrantz, PhD, Associate Professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD, Associate Professor, Reg Physiotherapist

Study Record Dates

First Submitted

July 9, 2025

First Posted

July 18, 2025

Study Start

November 1, 2025

Primary Completion (Estimated)

December 1, 2030

Study Completion (Estimated)

December 1, 2030

Last Updated

November 21, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations